Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2009
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation
John S Debenham, Christina B Madsen-Duggan, Junying Wang, et al.
Transgenic Research
|
August 22, 2000
Role of the melanocortin-4 receptor in metabolic rate and food intake in mice
A S Chen, J M Metzger, M E Trumbauer, et al.
Journal of Medicinal Chemistry
|
April 29, 2010
Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity
Lin Yan, Pei Huo, John S Debenham, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2005
Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists
Laura C Meurer, Paul E Finke, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 26, 2010
Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: synthesis and biological evaluation. Part 1
John S Debenham, Christina B Madsen-Duggan, Richard B Toupence, et al.
European Journal of Pharmacology
|
May 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Douglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
European Journal of Pharmacology
|
August 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Douglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 11, 2008
Discovery of imidazole carboxamides as potent and selective CCK1R agonists
Cheng Zhu, Alexa R Hansen, Thomas Bateman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist
Xiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics
|
September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
A S Chen, D J Marsh, M E Trumbauer, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2009
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation
John S Debenham, Christina B Madsen-Duggan, Junying Wang, et al.
Transgenic Research
|
August 22, 2000
Role of the melanocortin-4 receptor in metabolic rate and food intake in mice
A S Chen, J M Metzger, M E Trumbauer, et al.
Journal of Medicinal Chemistry
|
April 29, 2010
Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity
Lin Yan, Pei Huo, John S Debenham, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2005
Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists
Laura C Meurer, Paul E Finke, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 26, 2010
Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: synthesis and biological evaluation. Part 1
John S Debenham, Christina B Madsen-Duggan, Richard B Toupence, et al.
European Journal of Pharmacology
|
May 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Douglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
European Journal of Pharmacology
|
August 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Douglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 11, 2008
Discovery of imidazole carboxamides as potent and selective CCK1R agonists
Cheng Zhu, Alexa R Hansen, Thomas Bateman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist
Xiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics
|
September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
A S Chen, D J Marsh, M E Trumbauer, et al.
Page
of 14